Serogroup Y meningococcal disease in Chicago, 1991-1997

JAMA

Volumn 280, Issue 24, 1998, Pages 2094-2098

  Racoosin, Judith A ^a,c,d   Whitney, Cynthia G ^a,b   Conover, Craig S ^a,b,e   Diaz, Pamela S ^a  

^a CHICAGO DEPARTMENT OF PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e ILLINOIS DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD GROUP TYPING; COHORT ANALYSIS; DISEASE CONTROL; ELECTROPHORESIS; FEMALE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEROCONVERSION;

EID: 0032583433     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.24.2094     Document Type: Article

References (15)

1. Pinner RW, Gellin BG, Bibb WF, et al. Meningococcal disease in the United States, 1986. J Infect Dis. 1991;164:368-374.
2. Jackson LA, Wenger JD. Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989-1991. MMWR CDC Surveill Summ. 1993;42:21-30.
3. Galaid EI, Cherubin CE, Marr JS, Schaefler S, Barone J, Lee W. Meningococcal disease in New York City, 1973 to 1978: recognition of groups Y and W-135 as frequent pathogens. JAMA. 1980;244:2167-2171.
4. Centers for Disease Control. Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis. J Infect Dis. 1976;134:201-204.
5. Smilack JD. Group-Y meningococcal disease: twelve cases at an army training center. Ann Intern Med. 1974;81:740-745.
6. Koppes G, Ellenbogen C, Gebhart R. Group Y meningococcal disease in United States Air Force recruits. Am J Med. 1977;62:661-666.
7. Stephens DS, Hajjeh RA, Baughman WS, Harvey RC, Wenger JD, Farley MM. Sporadic meningococcal disease in adults: results of a 5-year population-based study. Ann Intern Med. 1995;123:937-940.
8. Dean AG, Dean JA, Burton AH, et al. Epi Info, Version 6: A Word Processing, Database, and Statistics Program for Epidemiology on Microcomputers. Atlanta, Ga: Centers for Disease Control and Prevention; 1994.
9. Selander RK, Caugant DA, Ochman H, et al. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol. 1986;51:873-874.
10. Bibb WF, Schwartz B, Gellin BG, et al. Analysis of Listeria monocytogenes by multilocus enzyme electrophoresis and applications of the method to epidemic investigations. Int J Food Microbiol. 1989;8:233-239.
11. Centers for Disease Control and Prevention. Control and prevention of meningococcal disease and control and prevention of serogroup C meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1997;46(RR-5):1-8.
12. Centers for Disease Control and Prevention. Serogroup Y meningococcal disease: Illinois, Connecticut, and selected areas, United States, 1989-1996. MMWR Morb Mortal Wkly Rep. 1996;45:1010-1013.
13. Hedrich AW. Recent trends in meningococcal disease. Public Health Rep. 1952;67:411-420.
14. Stanwell-Smith RE, Stuart JM, Hughes AD, Robinson P, Griffin MB, Cartwright K. Smoking, the environment and meningococcal disease: a case control study. Epidemiol Infect. 1994;112:315-328.
15. Lieberman JM, Chiu SS, Wong VK, et al. Safety and immunogenicity of a serogroup A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children: a randomized controlled trial. JAMA. 1996;275:1499-1503.